<DOC>
	<DOCNO>NCT01028326</DOCNO>
	<brief_summary>The World Health Organization recommend develop country incorporate pneumococcal conjugate vaccine ( PCV ) routine immunization schedule . The Kenya Ministry Health anticipate introduce new formulation PCV , PCV10 , routine childhood immunization schedule 2010 . In area Kenya designate monitor impact vaccine , catch-up campaign implement vaccinate child age 12-59 month . PCV10 find safe effective infant . It license use child 2 year age , use primary series child age 12 month evaluate . This study assess immunogenicity reactogenicity PCV10 first administer age 12-59 month .</brief_summary>
	<brief_title>PCV10 Reactogenicity Immunogenicity Study - Malindi</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Pneumococcal</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Age 1259 month Written inform consent Current febrile illness ( temperature &gt; 38.5Â°C ) Previous receipt pneumococcal vaccine Previous receipt DTPcontaining vaccine 1st year life Previous receipt hepatitis A vaccine Severe malnutrition ( mid upper arm circumference &lt; 11.5 cm ) serious medical condition ( e.g. , malignancy , AIDS , tuberculosis ) Seizures within previous 6 month progressive neurological illness Known allergy vaccine vaccine component Resident Kilifi Demographic Surveillance area Intention leave study area next 6 month</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>59 Months</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Pneumococcal pneumonia vaccine</keyword>
</DOC>